pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3622b |
Genomic Coordinates | chr8: 27701673 - 27701767 |
Description | Homo sapiens miR-3622b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3622b-3p | |||||||||||||||||||||||||||
Sequence | 58| UCACCUGAGCUCCCGUGCCUG |78 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CHMP1B | ||||||||||||||||||||
Synonyms | C10orf2, C18-ORF2, C18orf2, CHMP1.5, Vps46-2, Vps46B, hVps46-2 | ||||||||||||||||||||
Description | charged multivesicular body protein 1B | ||||||||||||||||||||
Transcript | NM_020412 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CHMP1B | |||||||||||||||||||||
3'UTR of CHMP1B (miRNA target sites are highlighted) |
>CHMP1B|NM_020412|3'UTR 1 CGGCAGAACCCGCTCTGAGGTTTCCTGGCCATAGCCACCCTTTGAAATGCTCTCTGTGTGTTAGAGAGATACTATACCCT 81 AGAAACTCTGAACACGCCAGAATGCTGAAATGCCCTTCTACCTTTGGGTTTACAGCCCCCTCCACATAAATTAAGAAATT 161 CAGTATTTCTGCACTCTTAGCTGGATTCTAAAGTTCTGTATAGCTCGTAATGATGGTATTTTTATAGCAGCCTTTTAACA 241 GAACTAGTTAATTTCGTGTATATGAATCTTTCTCGAAGATCTGGTCAAAACTGTATTCAGTTTCCTGCCCAGAATGATCA 321 GATTGAAGGTGGTTGGTTTTTATTATTATTTAGTGTGATTGATAGTATCTAGAATGGCAGGTGGTGCATAAAAGTTAAAG 401 AGAGGGGAAAGATTACTTAGTTTGGTTATACAGTTATAAACACCATGCAGTGTATTCGGTGGACTGTGCTATTTCTGTTT 481 ATCCTTTGGGTTTTGGTTTTTGTTTTTTTTTTTTTTGCCTTCACAGTGAGACTGCAAATGATTGTTCTCATAACGTATAT 561 TATTAATAAATGTGGTCCTATAATTTATACTGAAATTACCTTAGGATATTTTTGCATAATACTCTCTTACTGCTTACATT 641 CTATAAATTTTTCACGTGATAATTGTCTTTGCGTAACTGGGAAAAATGCCGAATAACTTCCTTTATTATCTGGAAAAATT 721 AAATTTGTTCATTTATATTTTCTACTTACTAAATTGAGTTTTTAAAAAGACTTAGTGTGACATTTGACAGTGTCTTTCAA 801 ACGAACTTCTCTAACAAGTTTATAGTTATTTTCCTGTTTCAACACTATTAGAAGTCTTATAAATTATGCTAATTAGCATG 881 GCAGTCATGTTACACACTCTTAACATTGCCAAAGAACTGTTGATTTCGTTTGAGAAAACCCTAGGACTGTGTGTGTGTAG 961 GTTTTGTTTTGATTTTAACAACCAAAAATAGAAATAAAATTAGAACTGCGTTTTAAGTTCTAATTTGCATTTATTAATTT 1041 GTCCAAAAGCAAGAACTCTTGGAAATCCTTGAAAATATAAGCTGGAATGTTTTACTTAGCCATGCAAGTCATTTATGTAT 1121 ACATCCAGCCAGCTGGAAATCTGAGAAGTAAAGAGGTAGGACTGGAAGGAAGGAGAAAGCTTGAGTCTTTAAGGCTAGAG 1201 CCCAGCTGTGCTGCCTGCCATCTTCTCAGGAATGGCAGTGCGTATTTTCTGGCTGAAAAGTAAAGCATGTATCCACCGCT 1281 TTCTCATAGCCTCGAAACATGGAGAAAAGCAACTTGCTTTTGCCTTGGCAAGCATGCTAACCTAAGTTAATTCAAGTTTT 1361 TTTTAACTTACCCTTTCCTTCACTGGAAGATTTTTCCATAAGAGAATTCCATTGTTTCAGAAAATAATTATAGGGGCCCT 1441 TCCAAGTTCTTTGAAAGATTCATAACCAACTATTCACTATTATAACATGTTTCCCAGTGTAAATGAGTAAGGAAAAAAAA 1521 AGTGTAACAGGTGCGTGCAGATGAGGAGTGACCCTCATATTTAAGTTATTTTATATTTGACTGGACATTGTTCAGAAGTG 1601 TGCTTTAAGGGACACTTGTTAGTTGTCTGCCCAGCATCTCTCAAGAATATCCCTCCTGTCCTCCACATGGTTGTGCAGGG 1681 CCATGTGTGAAGACAGCATGAGTCTTAACCCCTCTTTTATTTTATTTTTGAGACAGAGTCTCGCTCTGTTGCCCAGGCTG 1761 GAGTGCTGTGGCGCGATCTCTGCTCACTGCAACCTCCACCTCCCGGGTTCAAGTGATTCTCCTGCCTCAGCCTGCCGAGT 1841 AGCTGGAATTACAGGTGTGCACCACCATGCCCAGCTAGTTTTTTTGTATTTTTAGTAGAGACAGGGTTTCACTATGTTGG 1921 CCAGGCTGGTCTTGAACTCCTGACCTCAGGTGATCCGCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGCATGAGCC 2001 ACTGCACCTGGCCTTAACCCCTCTTTAGATTGGAAAAAATAATTACAACTTTAAAAATAGCTTAGTGTTGAACCCTTTGG 2081 TAAACTAAAGACCCTTTTATAATGCACATATTCCCAACAAAATTAATATATTTTGTGAGATTAAACAATGCTTGTATATG 2161 CTTGAACTTTCTTAAAATATGTCCATGTCATACTATTATGAATGTACATTTTTATGAGTCATAAATATTATTTTCAAAAG 2241 CACTACAGGCCCATGAATTACTTCCTCACTTTTGCAGTTGATTACTGAAATGTAAATCACAAGAATTTGTCAATTAAATC 2321 ATTTTAAACTGCATGTTA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760630. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_020412 | 3UTR | CUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903830 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_b |
Location of target site | NM_020412 | 3UTR | GAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_020412 | 3UTR | CCACCAUGCCCAGCUAGUUUUUUUGUAUUUUUAGUAGAGACAGGGUUUCACUAUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCAUGAGCCACUGCACCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_020412 | 3UTR | CCACCAUGCCCAGCUAGUUUUUUUGUAUUUUUAGUAGAGACAGGGUUUCACUAUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_020412 | 3UTR | AUGCCCAGCUAGUUUUUUUGUAUUUUUAGUAGAGACAGGGUUUCACUAUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_020412 | 3UTR | CACCACCAUGCCCAGCUAGUUUUUUUGUAUUUUUAGUAGAGACAGGGUUUCACUAUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCAUGAGCCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_020412 | 3UTR | AGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_020412 | 3UTR | CCAUGCCCAGCUAGUUUUUUUGUAUUUUUAGUAGAGACAGGGUUUCACUAUGUUGGCCAGGCUGGUCUUGAACUCCUGACCUCAGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCAUGAGCCACU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1084064 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_AbnovaAb |
Location of target site | ENST00000526991.2 | 3UTR | AGGUGAUCCGCCCACCUCAGCCUCCCAAAGUGCUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
102 hsa-miR-3622b-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT076713 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT080212 | PRKACB | protein kinase cAMP-activated catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT081398 | GTPBP3 | GTP binding protein 3, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT107158 | ZBTB43 | zinc finger and BTB domain containing 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT254071 | BACH1 | BTB domain and CNC homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT409790 | FOXO3 | forkhead box O3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448679 | MAPK9 | mitogen-activated protein kinase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450206 | ABHD15 | abhydrolase domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT486621 | PDK3 | pyruvate dehydrogenase kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489267 | TTLL1 | tubulin tyrosine ligase like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493117 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT494570 | BAK1 | BCL2 antagonist/killer 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497395 | RALY | RALY heterogeneous nuclear ribonucleoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT504900 | CCDC86 | coiled-coil domain containing 86 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505192 | USP46 | ubiquitin specific peptidase 46 | ![]() |
![]() |
2 | 4 | ||||||
MIRT506522 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | ![]() |
![]() |
2 | 6 | ||||||
MIRT508162 | ABCC5 | ATP binding cassette subfamily C member 5 | ![]() |
![]() |
2 | 8 | ||||||
MIRT508545 | PARVG | parvin gamma | ![]() |
![]() |
2 | 4 | ||||||
MIRT509850 | BIRC5 | baculoviral IAP repeat containing 5 | ![]() |
![]() |
2 | 6 | ||||||
MIRT510088 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT512094 | CRK | CRK proto-oncogene, adaptor protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT515381 | RPL7 | ribosomal protein L7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519176 | SCO1 | SCO1, cytochrome c oxidase assembly protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT519964 | ZCCHC8 | zinc finger CCHC-type containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522292 | NKAP | NFKB activating protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT523160 | HMGB2 | high mobility group box 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT525314 | FANCA | Fanconi anemia complementation group A | ![]() |
![]() |
2 | 2 | ||||||
MIRT528194 | PLEKHM2 | pleckstrin homology and RUN domain containing M2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532885 | ZNF451 | zinc finger protein 451 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538209 | CYR61 | cysteine rich angiogenic inducer 61 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539497 | ACTN4 | actinin alpha 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554600 | RRAGC | Ras related GTP binding C | ![]() |
![]() |
2 | 2 | ||||||
MIRT562444 | DCTN6 | dynactin subunit 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562748 | AOC3 | amine oxidase, copper containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565798 | SEC14L5 | SEC14 like lipid binding 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565838 | SCML2 | Scm polycomb group protein like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566072 | RCC2 | regulator of chromosome condensation 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566104 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | ![]() |
![]() |
2 | 2 | ||||||
MIRT572407 | MRPS14 | mitochondrial ribosomal protein S14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576198 | Vsig2 | V-set and immunoglobulin domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576313 | Acbd7 | acyl-Coenzyme A binding domain containing 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576651 | Mill2 | MHC I like leukocyte 2 | ![]() |
1 | 1 | |||||||
MIRT576859 | Socs6 | suppressor of cytokine signaling 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT606819 | BICD2 | BICD cargo adaptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT610738 | NUDT16 | nudix hydrolase 16 | ![]() |
![]() |
2 | 4 | ||||||
MIRT614798 | RORA | RAR related orphan receptor A | ![]() |
![]() |
2 | 2 | ||||||
MIRT619006 | NTMT1 | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619420 | NOS1AP | nitric oxide synthase 1 adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT620405 | MYO1H | myosin IH | ![]() |
![]() |
2 | 2 | ||||||
MIRT624869 | ABHD13 | abhydrolase domain containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633527 | ZFP30 | ZFP30 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT633927 | DNAH9 | dynein axonemal heavy chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636611 | CLIC5 | chloride intracellular channel 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640616 | MIOX | myo-inositol oxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT642605 | C14orf180 | chromosome 14 open reading frame 180 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644624 | SRSF2 | serine and arginine rich splicing factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655113 | PHLDA3 | pleckstrin homology like domain family A member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658976 | DNAJB5 | DnaJ heat shock protein family (Hsp40) member B5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT661495 | CHMP1B | charged multivesicular body protein 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT662996 | TMEM59 | transmembrane protein 59 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663075 | SFR1 | SWI5 dependent homologous recombination repair protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665405 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT666106 | SSR1 | signal sequence receptor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669562 | ALDOA | aldolase, fructose-bisphosphate A | ![]() |
![]() |
2 | 2 | ||||||
MIRT670070 | ZNF783 | zinc finger family member 783 | ![]() |
![]() |
2 | 2 | ||||||
MIRT671192 | ZNF891 | zinc finger protein 891 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675361 | KLHL26 | kelch like family member 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678857 | LINC00598 | long intergenic non-protein coding RNA 598 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679443 | C19orf52 | translocase of inner mitochondrial membrane 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684163 | ALDH1B1 | aldehyde dehydrogenase 1 family member B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684543 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684674 | SLC2A11 | solute carrier family 2 member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684971 | MINOS1 | mitochondrial inner membrane organizing system 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686006 | NEK4 | NIMA related kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687758 | KIAA1328 | KIAA1328 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688961 | ATXN3 | ataxin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689409 | UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI | ![]() |
![]() |
2 | 2 | ||||||
MIRT690001 | MMP17 | matrix metallopeptidase 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690165 | ELP3 | elongator acetyltransferase complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690202 | C5orf45 | MRN complex interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT690477 | ZNF33A | zinc finger protein 33A | ![]() |
![]() |
2 | 2 | ||||||
MIRT690566 | MICA | MHC class I polypeptide-related sequence A | ![]() |
![]() |
2 | 2 | ||||||
MIRT692160 | C10orf111 | chromosome 10 open reading frame 111 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693430 | PLGLB2 | plasminogen-like B2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693547 | ZNF708 | zinc finger protein 708 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693697 | PLGLB1 | plasminogen-like B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695006 | HSPA6 | heat shock protein family A (Hsp70) member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698525 | TFRC | transferrin receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT699574 | SIKE1 | suppressor of IKBKE 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703446 | FYTTD1 | forty-two-three domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT704397 | CTSS | cathepsin S | ![]() |
![]() |
2 | 2 | ||||||
MIRT704485 | CPT1A | carnitine palmitoyltransferase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT709822 | STPG1 | sperm tail PG-rich repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710859 | COQ7 | coenzyme Q7, hydroxylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT711893 | INSIG2 | insulin induced gene 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713796 | CPLX2 | complexin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718800 | C1GALT1C1 | C1GALT1 specific chaperone 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719501 | SEC24B | SEC24 homolog B, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT719722 | PDE6B | phosphodiesterase 6B | ![]() |
![]() |
2 | 2 | ||||||
MIRT722204 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723523 | CLPTM1L | CLPTM1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT725471 | GRAP2 | GRB2-related adaptor protein 2 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|